به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه « hodgkin's lymphoma » در نشریات گروه « پزشکی »

  • Akram Sardari, Mehrdad Salehi, Faeze Salahshour, Ali Mehrakizadeh, Babak Sattartabar *

    Cardiac involvement can occur in lymphoma, with the right heart being predominantly affected. The prognosis for patients with cardiac involvement is poor. A 28-year-old man, with a 4-year history of Hodgkin’s lymphoma, presented with progressive shortness of breath and ascites. Chest X-ray (CXR) and CT scan revealed multiple masses in the mediastinum. To exclude a pulmonary embolism, the patient underwent CT angiography, which incidentally revealed a filling defect in the right atrium. Trans-esophageal echocardiography confirmed the presence of a mass in the right atrium. Surgery was performed to obtain samples of the mediastinal masses and the right atrium mass. Pathological results indicated that the nature of the right atrium mass was diffuse large B-cell lymphoma (DLBCL), suggesting that the Hodgkin’s lymphoma had transformed into DLBCL. The transformation of Hodgkin’s lymphoma to DLBCL can occur, and cardiac involvement is not common. Given that the transformation of Hodgkin’s lymphoma into DLBCL can occur many years after the initial diagnosis, the authors recommend follow- up of these patients, as the prognosis may be worse than for non-transformed subtypes.

    Keywords: Hodgkin’s lymphoma, large Bcell lymphoma, Transformation, Right atrial mass}
  • صباحت حقی، رضا ارجمند*، مهری غلامی

    لنفوم هوچکین یکی از اقسام شایع لنفوم در کودکان و نوجوانان محسوب می شود که معمولا با  آدنوپاتی های  پابرجا  در ناحیه سر و گردن که به درمان آنتی بیوتیکی پاسخ نمی دهند، مشخص می شود. در موارد نادری تظاهر اولیه این بدخیمی در کودکان ، به صورت سندرومهای پارانیوپلاستیک، ایمونولوژیک و واسکولیتی می باشد. در اینجا  ما پسر 13 ساله ای را معرفی می کنیم که لنفوم هوچکین در وی  در ابتدا به صورت پورپورای هنوخ شوین لاین تظاهر پیدا کرد و منجر به مراجعه بیمار به مراکز درمانی گشت.

    کلید واژگان: لنفوم هوچکین, پورپورای هنوخ شوئن لاین, واسکولیت}
    Sabahat Haghi, Reza Arjmand*, Mehri Gholami

    Hodgkin's lymphoma is one of the most common types of lymphoma among children, usually characterized by persistent head and neck adenopathies that are unresponsive to antibiotic treatment. In rare cases, the primary manifestation of this malignancy includes paraneoplastic, immunological, and vasculitic syndromes in children. Here, we introduce a 13-year-old boy, and Hodgkin's lymphoma was initially manifested as Henoch-Schonlein purpura and eventually led to his hospitalization.

    Keywords: Hodgkin's lymphoma, Henoch-Schonlein purpura, Vasculitis}
  • زینب عساکره، الهام مراغی، بیژن کیخایی، امل ساکی مالحی*
    زمینه و هدف

    در بسیاری از تحقیقات پزشکی، رگرسیون خطرات متناسب کاکس برای بررسی توزیع بقای بیماران سرطانی، مبتنی بر گروه بندی های دموگرافیک و کلینیکی به کار برده می شود. هدف از این مطالعه تعیین عوامل موثر بر بقای بیماران مبتلا به لنفوم هوچکین با استفاده از روش ناپارامتری جنگل تصادفی بقا (RSF) و مقایسه آن با مدل خطرات متناسب کاکس است.

    روش بررسی

    در این مطالعه کوهورت گذشته نگر، پرونده های تمامی بیماران مبتلا به لنفوم هوچکین که در طی سال های 1381 (فروردین) تا 1391 (اسفند) به مرکز آنکولوژی و هماتولوژی بیمارستان شفای اهواز مراجعه نمودند، مورد بررسی قرار گرفتند. بقای بیماران از زمان تشخیص اولیه بیماری تا عود بیماری محاسبه شد. برای ارزیابی روند بیماری، ویژگی های جمعیت شناختی و متغیرهای مربوط به بیماری (شامل مرحله بیماری، شیمی درمانی، محل درگیری لنف و غیره) از پرونده 387 بیمار مبتلا به لنفوم هوچکین استخراج شد. تحلیل داده ها با نرم افزار R4.0.3 و با استفاده بسته های survival و RandomForestSRC انجام شد.

    یافته ها: 

    نتایج حاصل از مدل کاکس نشان می دهد که LDH (001/0=P) و طبقه بندی کلاسیک لنفوم (001/0<p) معنادار می باشند. نتایج برازش مدل RSF نشان داد که مهمترین متغیرهای موثر بر عود به ترتیب مرحله بیماری، شیمی درمانی، طبقه بندی کلاسیک لنفوم و هموگلوبین بودند. همچنین مدل RSF براساس شاخص های مناسبت مدل (شاخص هماهنگی=9/84) نسبت به مدل کاکس (شاخص هماهنگی=6/57) عملکرد بهتری داشت.

    نتیجه گیری: 

    در صورتی که تعداد متغیرها زیاد بوده و بین متغیرها رابطه وجود داشته باشد، مدل RSF، متغیرهای مهم و تاثیرگذار بر بقای بیماران را بدون نیاز به پیش فرض های محدودکننده با دقت بالا نسبت به مدل کاکس شناسایی می کند.

    کلید واژگان: مدل کاکس, لنفوم هوچکین, عود, جنگل تصادفی, بقا}
    Zeinab Asakereh, Elham Maraghi, Bijan Keikhaei, Amal Saki Malehi*
    Background

    In many studies, Cox regression was used to assess the important factors that affect the survival of cancer patients based on demographic and clinical variables. The aim of this study was to determine the factors affecting the survival of patients with Hodgkin's lymphoma using the random survival forest (RSF) method and compare it with the Cox model.

    Methods

    In this retrospective cohort study, all patients with Hodgkin's lymphoma who were referred to the Oncology and Hematology Center of Ahvaz Shafa Hospital from March 2000 to February 2010 were included. The survival time was calculated from diagnosis to the first recurrence event date (based on month). To assess the process of the disease, demographic characteristics and disease-related variables (including disease stage, chemotherapy, site of lymph involvement, etc.) were extracted from the records of 387 patients with Hodgkin's lymphoma. To investigate the prognostic factors that affect the recurrence of disease the Cox model and RSF were implemented. Moreover, their performance based on the C-index, IBS, and predictor error rate of the two models were compared Data analysis was implemented by using R4.0.3 software (survival and RandomForestSRC packages).

    Results

    The results of the Cox model showed that LDH (P=0.001) and classical lymphoma classification (P<0.001) were associated with an increased risk of relapse in patients. However, the results of the RSF model showed that the important variables affecting the recurrence of disease were the stage of disease, chemotherapy, classical lymphoma classification, and hemoglobin, respectively. Also, the RSF model showed a higher (c-index=84.9) than the Cox model (c-index=57.6). Furthermore, the RSF model revealed a lower error rate predictor (0.09) and IBS index (0.175) than the Cox model. So, RSF has performed better than the Cox model in determining prognostic factors based on the suitability indicators of the model.

    Conclusion

    The RSF has high accuracy than the Cox model when there is a high number of predictors and there is collinearity. It can also identify the important variables that affect the patient's survival.

    Keywords: cox model, hodgkin's lymphoma, recurrence, random forest, survival}
  • لیلا رضایی*، فریبا شیخی شوشتری، ناصر آقایی
    زمینه و هدف

    سندروم هورنر یک بیماری نادر با سه علامت بالینی پتوز، میوز و آنهیدروز  یک طرفه‏ی صورت و گردن است. در این سندروم، لنفوم هوچکین به عنوان یکی از علل مسبب تهدید‏کننده‏ی حیات مطرح است. مطالعه‏ی حاضر با هدف گزارش و معرفی یک بیمار مراجعه‏کننده به بیمارستان آموزشی درمانی امام خمینی (ره) شهر کرمانشاه با تشخیص  سندروم هورنر و  لنفوم هوچکین انجام گرفت.

    معرفی بیمار

     بیمارآقای 30 ساله با علایم بالینی پتوز، میوز و عدم تعریق سمت چپ بالا تنه و صورت به همراه آنیزوکوریا می‏باشد. در سونوگرافی سمت چپ گردن لنفادنوپاتی همراه درگیری مدیاستن فوقانی مشاهده شد.MRI  مغز و نخاع  نرمال گزارش شد. در گرافی از قفسه‏ی سینه لنفادنوپاتی ناف ریه مشاهده شد.  در پایان پس از بیوپسی از لنف نود گردنی تشخیص لنفوم هوچکین مطرح شد.

    نتیجه ‏گیری

     با توجه به نتایج این مطالعه مبنی بر  تایید لنفوم هوچکین در بیمار، علاوه بر  بررسی کل مسیر اکولوسمپاتیک، بررسی از نظر نیوپلاسم‏ها از جمله لنفوم هوچکین با توجه به بالا بودن پتانسیل درمان آن ضروری است. همچنین با توجه به درگیری مدیاستن فوقانی می‏توان اظهار داشت که سندروم هورنر یک تظاهر اولیه‏ی غیر معمول بیماری هوچکین است که به دلیل آسیب به مسیر اکولوسمپاتیک ناشی از فشار بر مدیاستن ایجاد می‏شود.

    کلید واژگان: سندروم هورنر, نئوپلاسم, لنفو م هوچکین, Horner's Syndrome, Neoplasm, Hodgkin's lymphoma}
    Leila Rezaei*, Fariba Sheikhi Shooshtari, Naser Aghaei
    Background & Aims

    Horner's syndrome is a rare disease with three clinical signs of ptosis, miosis and unilateral anhydrosis of the face and neck. In this syndrome, Hodgkin's lymphoma should be considered as one of the first life-threatening symptoms. Horner's syndrome, or oculosympathetic paralysis, is a rare disease first reported by Mr. Horner (1883-1886) with three clinical signs including unilateral ptosis, miosis, and Unilateral and unilateral anhidrosis of the face and neck were described, all due to involvement of the oculosympathetic pathway (1). Horner syndrome results from an interruption of the oculosympathetic pathway. This condition does not usually cause vision problems or other significant symptoms, but is important as a warning sign that the oculosympathetic pathway has been interrupted, potentially with serious and even life-threatening processes. The oculosympathetic pathway has a long and circuitous course, beginning in the brain and traveling down the spinal cord to exit in the chest, then up the neck and into the orbit. The sympathetic nervous supply is responsible for the dilation of the pupil (mydriasis). When disrupted, parasympathetic supply is uninhibited, and constriction of the pupil (miosis) ensues. The reaction of the pupils to light and accommodation is normal as those systems do not depend on sympathetic nerve supply. Therefore, this syndrome with unimpressive clinical findings and insignificant symptoms may be a sign of serious pathology in the head, chest, or neck. Patients with Horner syndrome present with a slightly droopy upper lid and a smaller pupil on the affected side; less commonly, there is a deficiency of sweating over the brow or face on the affected side (2). Horner syndrome is almost always diagnosed clinically, though pharmacological testing can be used to confirm the diagnosis. Imaging modalities such as PET, CT and MRI are important components of work‐up for patients presenting with acquired Horner syndrome (3). Factors that cause this disease include trauma, brain tumors, migraines, cluster headaches, hyperthyroidism, and lung cancer(4). Because Horner syndrome sometimes occurs as the first sign of a life-threatening condition, a thorough post-diagnosis systemic examination is necessary to follow up on patients for signs and symptoms (5). This is a clonal malignancy (dependent on asexual reproduction) of the lymphatic system with different clinical manifestations that can be treated in the early and advanced stages (6). Horner's syndrome is an unusual initial manifestation of Hodgkin's disease, and, in this case, it was due to oculosympathetic damage from mediastinal compression (7, 8). The aim of this study was to report and introduce a patient referred to Imam Khomeini Hospital in Kermanshah with a diagnosis of Horner's syndrome and Hodgkin's lymphoma.

    Case Presentation

    The patient is a 30-year-old man with left ptosis about 50 days before seeing an ophthalmologist. The patient also complains of sweating on the right side of the body and lack of sweating on the left side of the upper torso and face. No previous history of specific illness or family history of the symptoms were reported. In ocular examinations, the corrected vision of both eyes is equal to 10/10, normal eye movements, mild ptosis in the range of 2 mm in the left eye, meiosis of the left eye and the development of Anisocoria (an ocular complication in which the pupil of one eye from Size differs from other pupils.) Was reported more clearly in low light. According to the mentioned symptoms, Horner syndrome was presented to the patient. A complete and appropriate examination is sufficient for the initial diagnosis of this syndrome, but in order to confirm the diagnosis and determine the location of the injury, naphazoline drops were used. In this way, this drop was poured in both eyes of the patient and after a few minutes, the ptosis disappeared and the amount of anisocoria decreased. At present, after starting treatment, in addition to improving anisocoria, the amount of ptosis has decreased and the patient is satisfied with continuing treatment. On systemic examination, several large lymph nodes on the left side of the neck were touched in the area of the sternocleidomastoid muscle (SCM). Ultrasound of this area also showed a lymphadenopathy measuring 15 x 25 mm deep in the SCM muscle in the subclavian space (Subclavian triangle) and a lymph node measuring 10 x 15 mm in the upper region of the supraclavicular space with involvement of the upper mediastinum. MRI (Magnetic resonance imaging) of the brain and spinal cord was also reported to be normal. An X-ray of the chest showed umbilical cord lymphadenopathy. Finally, after biopsy of Hodgkin's lymph node, the diagnosis of cervical lymph node was made.

    Conclusion

    In the present report, after examining the patient, Horner syndrome was clinically confirmed and after Hodgkin's lymph node biopsy, the diagnosis of Hodgkin's lymphoma was made. Involvement was also seen in the SCM muscle area and the upper mediastinum. In line with the results of the present study in a study by Simon et al. Conducted in 1985 on a 22-year-old woman with Horner syndrome, a mass in the mediastinum was observed on a patient's chest X-ray and evaluated. Further leads to the diagnosis of Hodgkin. This study suggests that Horner's syndrome is an unusual early manifestation of Hodgkin's disease caused by damage to the oculosympathetic pathway due to pressure on the mediastinum(9). A 1980 study by Maloney et al. On 450 patients with Horner's syndrome reported less than 3 percent of Hodgkin's lymphoma(7). Another study by Giles et al. In 1958 on 216 patients with Horner syndrome identified three cases of Hodgkin's lymphoma(6). Also, a 1940 study by Goldman et al., Conducted on 212 patients with Hodgkin's disease, reported no cases of Horner's syndrome(10). Kaplan also stated in his 1980 study that no cases of the syndrome were observed in patients with Hodgkin's disease(11). However, in the present report, MRI of the patient's brain and spinal cord was normal and no complication was observed. However, Williams et al., In their 1959 study of the complications of leukemia and lymphoma, found that neurological complications occur in 15% of patients with Hodgkin's lymphoma(12). Jackson et al., Who studied Hodgkin's disease in 1945, also noted complications such as brain and spinal cord injuries, polyneuropathy, mononorrhea, and myopathy(13).According to the results of this study, with the confirmation of Hodgkin's lymphoma in the patient, it is necessary that in addition to the entire oculosympathetic pathway, the patient be examined for neoplasms, including Hodgkin's lymphoma, due to its high potential. Also, due to the involvement of the upper mediastinum, it can be stated that Horner's syndrome is an unusual initial manifestation of Hodgkin's disease, which is caused by damage to the oculosympathetic pathway due to pressure on the mediastinum. In general, according to the results of the present study and similar studies among the early life-threatening symptoms, although Hodgkin's disease has been reported as uncommon, but due to the high potential for its treatment, it should be Patients with this syndrome should be considered. Also, with the publication of the present study, we can point to the sensitivity among ophthalmologists in identifying certain cases of malignancies associated with Horner's syndrome, which can lead to their early detection and better prognosis. Unfortunately, the lack of similar Iranian and foreign studies and the unavailability of the full text of some other articles for comparison prevented a comprehensive decision on the results.

    Keywords: Horner's Syndrome, Neoplasm, Hodgkin's lymphoma}
  • Aswin Nagarajan *, Ganesharajah Selvaluxmy, Ramya Ravichandar, Shirley Sundersingh

    The patients with multiple malignancies are difficult to diagnose as one malignancy may be indolent and usually diagnosed as an incidental finding, while proceeding with staging work-up for the other malignancy. Treating such patients is even more difficult due to the issues related to sequencing the treatment for each of them. We report a case study where a patient was diagnosed with dual malignancies (Hodgkin’s lymphoma and adenocarcinoma lung) and was treated for both malignancies sequentially. The patient had five years of disease-free survival and was kept under follow-up. He was diagnosed with metachronous malignancy, squamous cell carcinoma of esophagus, and underwent treatment for the same condition.

    Keywords: Hodgkin’s lymphoma, Adenocarcinoma, Squamous cell carcinoma, Diseasefree survival, Case report}
  • Nishit Gupta, Aditi Mittal, Rajan Duggal, Tina Dadu, Amit Agarwal, Anil Handoo

    Hodgkin lymphoma variant of Richter’s transformation (HL-RT) is a rare event, occurring in < 1% chronic lymphocytic leukemia (CLL) cases, of which, in < 10% cases, HL is the first finding leading to a diagnosis of CLL that co-exists simultaneously. Here we report a 60 years old male patient who presented with an outside diagnosis of lymphocyte-rich classical HL. On evaluation, he had only B-symptoms in the form of low-grade fever and weight loss. Peripheral smear revealed mild leukocytosis with an absolute lymphocytosis and a few smudge cells. Bone marrow (BM) aspirate and biopsy exhibited diffuse infiltration by a small cell, low grade, Non-Hodgkin’s lymphoma with no immunohistochemical evidence of HL. Flow cytometry performed on BM was consistent with classical immunoprofile of CLL. Meanwhile the lymph node received for review revealed diffuse effacement of nodal architecture by small mature lymphocytes with immunoprofile of CLL expressing CD20, CD5, and CD23. Interspersed between these cells, were a few eosinophils along with classical Reed Sternberg cells, expressing CD30, MUM-1, CD15, and dim PAX-5, with a surrounding rosette of T-Cells highlighted by CD3 and PD-1 and negative for CD45, CD20, and EBV immunohistochemistry. Fluorodeoxyglucose positron emission tomography (FDG-PET) scan revealed hepatosplenomegaly with multiple supra/infra diaphragmatic lymph nodes. So, a final diagnosis of HL-RT in CLL was considered. The patient is currently doing well after the first cycle of ABVD chemotherapy. HL-RT occurring in CLL is a rare event with heterogeneous clinical presentation, morphology, clonal origin, disease course, prognostic features, and survival.

    Keywords: Hodgkin’s Lymphoma, Richter’s transformation, Chronic lymphocytic leukemia (CLL), Epstein-Barr virus (EBV), Fluorodeoxyglucose positron emission tomography (FDG-PET) scan, Adriamycin, Bleomycin, Vinblastine, Dacarbazine (ABVD) chemotherapy}
  • Navid Mohseni, AliAkbar Khadem Maboudi*, Ahmadreza Baghestani, Anahita Saeedi
    Introduction

    Hodgkin lymphoma (HL) is an uncommon cancer of lymphocytes, characterized by cancerous Reed-Sternberg cells in an inflammatory background. HL is an exceptionally curable disease with combination chemotherapy, radiotherapy, or combined modality treatment. This analysis aimed to identify significant prognostic factors on the cure rate.

    Materials and Methods

    The medical records of 110 patients hospitalized from 2007 up to 2014 with 18 months follow-up was retrospectively reviewed in Taleghani hospital of Tehran, Iran. The survival time was set as the time interval between diagnosis and a patient's death from HL. Also, if the cure rate was present in survival, data encompasses zero frailty. Thus, using hyper-Poisson (hP) distribution as discrete frailty, the unobserved heterogeneity and random effects were accounted for.

    Results

    The estimated cure fraction was 81.2%, which was obtained after 2717 days (7.4 years). In noncured cases, the mean survival time was 1535 days (4.2 years). Also, the five and ten-year survival rates were 0.91 and 0.80, respectively. After diagnosis, results revealed that patients with age 45, hemoglobin 12, WBC 15000, and BMI 30 were associated with poor outcome by using simple analysis.More importantly, there is no significant difference between males and females in the cure of HL patients.

    Conclusion

    As expected, the study indicated that a high proportion of HL patients got cured. A cure rate model with discrete frailty utilization provided a suitable way to account for heterogeneity among HL patients.

    Keywords: Hodgkin’s Lymphoma, Survival Analysis, Cure Rate Model, Discrete Frailty}
  • Ali Zare Mehrjerdi, Mahdie Ahmadi*
    Background

    Hodgkin’s lymphoma is one of the most commonly diagnosed lymphomas in Western society. Today Reed-Sternberg cells are identified by positive staining of several biomarkers. The IMP3 (insulin-like growth factor II m-RNA-binding protein 3) marker is a member of the insulin-like growth factor II mRNA binding protein family that has been suggested as a diagnostic marker in some epithelial malignancies. In this study, we aimed to evaluate the expression profile of IMP3 in Hodgkin’s lymphoma patients and compare it with those with large cell lymphoma.

    Methods

    In this study, patients diagnosed with Hodgkin’s lymphoma between 2016 and 2018 were recruited. For the control group, patients diagnosed with large cell lymphoma were chosen. Paraffin blocks were collected and cut by a microtome machine. Immunohistochemical staining was performed on the slides for the IMP3 marker, using the Envision method. The color intensity was divided into four groups, and data on age, gender, staining intensity, sampling rate, and staining pattern entered at the end of the checklists. The collected data were analyzed using SPSS 19 software. The paired t-test has was employed, and a significant statistical level of 0.05 was considered in all tests.

    Results

     In this study, 145 patients in a wide range of 5 to 84 years (the mean age = 41 ± 17 years) were studied. Fifty-three patients were diagnosed with diffuse large B-cell lymphoma (36.6%), 4 cases (2.8%) with anaplastic large cell lymphoma and 88 cases with (60.7%) Hodgkin’s lymphoma. Among 145 patients in the current study, 143 patients (98.6%) were positive for IMP3. IMP3 was positive in all patients with Hodgkin’s lymphoma and anaplastic large cell lymphoma, and only 2 cases of diffuse large B-cell lymphoma were negative for this maker, in whom severe necrosis was noted. Consequently, there is not a vivid difference between Hodgkin’s lymphoma and non-Hodgkin’s lymphoma (p-value=0.153)

    Conclusion

    The marker is positive for Hodgkin’s lymphoma with a negative background and may be used as a supplementary marker along with CD15 and CD30 to detect neoplastic cells. However, it cannot help differentiate it from large cell lymphomas because it is also positive for non-Hodgkin lymphomas.

    Keywords: Hodgkin’s Lymphoma, Lymphoma, Non-Hodgkin, IMP3, CD15, CD30}
  • امیر الهایی، امل ساکی مالحی *، محمد ثقت الاسلام
    زمینه و اهداف

    ارزیابی متغیر های تاثیرگذار بر عود لنفوم هوچکین یکی از مباحث مهم مطالعات بالینی است. مدل رگرسیون کاکس به عنوان یک مدل مشهور می تواند برای ارزیابی این فاکتور ها بکار گرفته شود. این مدل براساس پیش فرض خطرات متناسب به برسی متغیر های پیش آگهی می پردازد. این مطالعه با هدف ارزیابی مدل کاکس طبقه بندی شده و کاربرد آن در شناسایی عوامل موثر بر زمان عود بیماری لنفوم هوچکین در بیماران بستری در بیمارستان شفای اهواز انجام شد.

    مواد و روش ها

    در پژوهش حاضر پرونده ی تمامی بیمارانی که از سال 1381 تا سال 1391 با تشخیص لنفوم هوچکین به مرکز آنکولوژی و هماتولوژی بیمارستان شفا در شهرستان اهواز مراجعه کرده بودند، مورد بررسی قرار گرفت. زمان بقاء، مدت زمان از تشخیص بیماری تا عود (بر حسب ماه) پس از درمان از طریق شیمی درمانی در نظر گرفته شد. انتخاب بهترین مدل با استفاده از آماره نسبت درست نمایی مورد بررسی قرار گرفت. تحلیل داده ها در نرم افزار STATA13  انجام شد.

    یافته ها

    نتایج حاصل از برازش مدل رگرسیون کاکس طبقه بندی شده نشان می دهد که  خطر عود برای افرادی که هموگلوبین کمتراز 10/5 دارند نسبت به افرادی که هموگلوبین بالای 10/5 دارند 2 برابر می باشد (0/012= P-value) و برای افراد که با روش NLPHL نمونه برداری می شوند نسبت به کسانی که با روش CHL نمونه برداری می شوند 96درصدبیشتر می باشد (P-value=0/155).

    نتیجه گیری

    با استفاده از مدل کاکس طبقه بندی شده بدون اثر متقابل، هموگلوبین کمتر از 10/5 یکی از عوامل مهم و معنادار بر زمان  عود بیماری افراد  مبتلا به لنفوم هوچکین می باشد.

    کلید واژگان: لنفوم هوچکین, آنالیز بقاء, عود, مدل کاکس طبقه بندی شده}
    Amir Elhaei, Amal Saki Malehi*, Mohammad Seghatoleslami
    Background and Objectives

    Identifying the important influential factors of relapse in Hodgkin's Lymphoma is a great challenge in oncology studies. Cox regression model is a known method that could be used to evaluate the prognostic factors. This method identifies the main prognostic factors based on Proportional Hazard (PH) assumption. The aim of this study was to evaluate the stratified Cox model and assess the prognostic factors which affected the relapse time of Hodgkin's lymphoma in patients hospitalized in Ahvaz Shafa Hospital.

    Material and Methods

    The current study included all the cases of patients who had referred to the research center of oncology and hematology of Shafa hospital in Ahvaz Jundishapure University of medical sciences during 2002-2012. Survival time was considered from date of diagnosis to relapse (in months) after chemotherapy. Choosing the best model was based on Likelihood Ratio Test. Data analysis was performed using STATA13.

    Results

    The results of the stratified Cox regression model showed that the risk of relapse is 2 times higher for patients with hemoglobin lower than 10.5 (P=0.012). Furthermore, the patients that NLPHL was used as a biopsy method were 96 percent more likely to experience the relapse compared to CHL biopsy method (P = 0.155).

    Conclusion

    Using the stratified Cox regression model the hemoglobin less than 10.5 was identified as a main and significant prognostic factor.

    Keywords: Hodgkin's Lymphoma, Survival Analysis, Relapse, Classified Cox Model}
  • Zakie Nasiri, Zahra Kiamanesh, Farnaz Banezhad, Farshad Emami, Ramin Sadeghi *
    We report a case of Hodgkin lymphoma (classic type) referred for response assessment after two cycles of chemotherapy with ABVD regiment. The F-18 fluorodeoxyglucose positron emission tomography (F-18 FDG PET/CT) showed hypermetabolic cutaneous and subcutaneous lesions with a linear pattern in the left arm with significant F-18 fluorodeoxyglucose positron accumulation in associate with left axillary hypermetabolic lymph nodes. She presented with left arm pruritic rash accomplished by pain from two weeks ago. On clinical examination, painful papulovesicular rash with palpable enlarged axillary lymph node were noted. These findings were compatible with cutaneous herpes zoster infection of the left arm along with axillary reactive lymphadenopathy.
    Keywords: Active herpes infection, Hodgkin’s lymphoma, Clinical examination, Nuclear medicine}
  • Nematollah Rostami, Zohreh Maghsoomi *, Farzad Dashti
    Introduction
    One of the rare platelet dysfunction, which is impairment of receptor GPIIb/IIIa and platelet aggregation defect, is acquired Glanzmann’s thrombasthenia. A common cause of this thrombasthenia is an autoantibody or plasma protein inhibitor against a normal GPIIb/IIIa glycoprotein.
    Case Presentation
    In this case report, a 28-year-old female with a history of treated Hodgkin’s lymphoma presented with a menometrorrhagia and ecchymosis. Before that, she had no bleeding history and there was no family history bleeding tendency. Laboratory findings revealed bleeding time > 10 minutes, normal partial thromboplastin time (APTT), prothrombin time (PT), fibrinogen, and von Willebrand factor. Platelet-aggregation studies showed no aggregation to adenosine diphosphate (ADP), collagen, and a normal response to ristocetin. The clinical history, medical history, and laboratory findings supported a diagnosis of acquired Glanzmann’s thrombasthenia. Imaging revealed significant lymph nodes was compatible with recurrent disease. The patient’s menorrhagia and bleeding tendency were controlled by systemic chemotherapy.
    Conclusions
    This report shows the association of acquired thrombasthenia with the recurrent Hodgkin’s lymphoma, which can be controlled by remission induction chemotherapy.
    Keywords: Glanzmann’s Thrombasthenia, Hodgkin’s Lymphoma, Acquired Thrombasthenia}
  • Shravan Kanaparthi, Shrikiran Aroor, Suneel C. Mundkur, Sowmya Shashidhara, Kasi Viswanath Reddy
    Hodgkin’s Lymphoma is one of the commonly encountered lymphomas in childhood. Most of the children present with lymphadenopathy. A rare subset of children do present with constellation of atypical symptoms as paraneoplastic syndromes. We hereby present an 11-year-old boy with classical Hodgkin’s Lymphoma associated with Alopecia areata and demyelination as paraneoplastic manifestations. Both these paraneoplastic manifestations improved after initiating chemotherapy (ABVD regimen). A high index of suspicion for underlying malignancy would help clinicians in clinching an early diagnosis and would avert the associated complications.
    Keywords: Hodgkin's lymphoma, Paraneoplastic syndrome, Alopecia areata, Pontine myelinolysis}
  • Severyn Myronovskij, Olga Shalay, Veronika Spivak, Rostyslav Stoika, Yuriy Kit*
    Blood serum has been extensively explored as a source of the bio-markers [1, 2]. For concentration of minor protein(s) and depletion of abundant blood serum proteins a 2,2,2-trichloroacetic acid (TCA) precipitation procedure is frequently applied [3]. However, a significant amount of proteins may be present in the TCA extracts, and these proteins are often not studied.Recently, we have shown that a TCA-extracted fraction obtained from blood serum of the multiple sclerosis (MS) patients contains two proteins that were identified by the MALDI TOF/TOF as blood serum albumin (BSA) and a short form of the unconventional myosin lc (sMyo1C) [4]. We also demonstrated that the TCA-extracted fractions isolated from blood serum of the MS patients contain IgGs and/or their heavy chains [5]. These proteins have not been detected in the TCA-extracted fractions isolated from blood serum of healthy human donors and patients with the systemic lupus erythematosus or the rheumatoid arthritis.Here we report that the TCA-soluble fraction isolated from blood serum of the non-Hodgkin’s lymphoma contains sMyo1C that have been earlier detected in blood serum of the MS patients, while the blood serum of the multiple myeloma patients, in addition to that protein and albumin, also contains the IgG polypeptides.
    Keywords: blood serum, TCA, extracted proteins, non, Hodgkin's lymphoma, multiple myeloma, bio, markers}
  • Fatemeh Javanmardi, Amal Saki-Malehi, Ahmad Ahmadzadeh, Fakher Rahim
    Background
    Hodgkin's lymphoma (HL) is a unique cancer of lymphocytes that has unknown reason. As lymphocytes are found throughout the lymphatic system, HL can start almost anywhere in the body. It usually starts in a group of lymph nodes in one part of the body; it usually spreads in a predictable form, from one group of lymph nodes to the next. Eventually, it can spread to almost any tissue or organ in the body through the lymphatic system or the bloodstream. So it's important to evaluate the prognostic factors of mortality and recurrence. The aim of this study is to use multistate model to consider the event history of patients and assess important prognostic factors.
    Materials And Methods
    We performed a retrospective review on 389 patients with Hodgkin's disease referred to the Oncology and Hematology Center, Shafa Hospital, Ahvaz during 2002 and 2012. An illness – death model was fitted to assess the hazard of transitions during the course of the disease for each prognostic factor.
    Results
    The results showed that the prevalence rate was higher in male population ≥50 years of age with a hemoglobin level of less than 10.5 g per deciliter and diagnosis of advanced stage of disease. The risk of death for males was twice more than females (HR=2.07). Moreover, patients with mediastina and spleen involvement were more than others in danger of death (1.66 and 1.36, respectively).
    Conclusion
    In conclusion, the multistate model offers an appropriate method to consider the event history of patients and determine main prognostic factors, which play an important role in rapid diagnosis and choosing the best treatment choice for each patient.
    Keywords: Hodgkin's lymphoma, Multistate model, Prognostic factors, Markov illness-death model}
  • افسون شریعت *
    : ویروس اپشتین بار با سرطان نازوفارنکس، لنفوم بورکیت و لنفوم هوجکین مرتبط است. هدف از این تحقیق شناسایی میزان فراوانی ویروس اپشتین بار در نمونه های بافتی بیماران مبتلا به لنفوم هوجکین با روش ایمونوهیستوشیمی در استان فارس می باشد.
    تعداد 30 نمونه بافتی لنفوم هوجکین از بلوک های پارافینه فیکس شده در فرمالین از بیمارستان های استان فارس انتخاب شدند و بیان پروتئین ویروسیLMP1 با روش ایمونوهیستوشیمی ارزیابی گردید. داده ها با نرم افزار آماری SPSS و آزمون دقیق فیشر آنالیز شدند.
    کلید واژگان: ویروس اپشتین بار, لنفوم هوجکین, ایمونوهیستوشیمی, استان فارس}
    Afsoon Shariat*
    Background And Aims
    Epstein Barr virus is associated with nasopharyngeal carcinoma, Burkitt lymphoma and Hodgkin's lymphoma. The aim of this study was to detect the frequency of EBV in tissue specimens from patients with Hodgkin's lymphoma in the Fars province using the immunohistochemical method.
    Materials And Methods
    A number of 30 cases of Hodgkin’s lymphoma tissue samples were selected from formalin-fixed paraffin embedded blocks from the Fars province hospitals in 2016 and the expression of LMP1 was evaluated using the immunohistochemical method. Data were analyzed using SPSS statistical software and Fisher’s exact test.
    Results and
    Conclusions
    A total of 77% of the samples (23 of 30), were presented with Epstein-Barr virus and positive cases included 16 males and 7 females. Eighty seven percent (7 of 8) of the Hodgkin’s lymphoma patients infected with EBV were in the age group 1-14 years, 60% (3 of 5) in the age group of 15-49 years and 76% (13 of 17) in the age group over 49 years. The highest expression rate of the virus was seen among mixed cellularity Hodgkin’s lymphoma subtype (93%). According to the Fisher’s exact test, there was no significant correlation in the prevalence of EBV subtypes among different sex and age groups (p values > 0.05). The results showed a high expression of EBV among Hodgkin’s lymphoma specimens of children and adults in the Fars province. Also, the prevalence of EBV was higher among males compared to females and mixed cellularity was the predominant subtype. These results are similar to that in other developing countries.
    Keywords: Epstein-Barr virus, Hodgkin's lymphoma, Immunohistochemistry, Fars province}
  • Shirin Kouhpayeh, Alireza Andalib*, Marjan Gharagozloo, MohammadHossein Sanei, Nafi seh Esmaeil, Mohammad Reza Maracy
    Background

    The objective of this study is to indicate the role of urokinase plasminogen activator receptor (uPAR), soluble uPAR (suPAR), and β1 integrin in tumor growth and invasion of lymph nodes from Hodgkin’s lymphoma (HL) patients.

    Materials and Methods

    In this study, 25 lymph nodes from HL patients were analyzed for the expression of β1 integrin and uPAR on mononuclear cells using two-color fl ow cytometry and immunohistochemical analysis. Moreover, the levels of suPAR in the serum samples of HL patients were measured and compared with 32 healthy controls.

    Results

    Flowcytometry and immunohistochemical results indicated no signifi cant association of uPAR expression with tumor size, different stages, or different histological subtypes of HL; however, an increased expression of β1 integrin was detected in the advanced stages of HL. Higher expression of β1 integrin was detected in nodular sclerosis compared to lymphocyte predominant. No signifi cant difference was observed between the serum levels of suPAR in patients with different stages of HL and healthy controls. Moreover, the levels of suPAR were signifi cantly higher in nodular sclerosis in comparison with other subtypes.

    Conclusions

    This study showed that the levels of suPAR and β1 integrin varied between different histological subtypes of HL. Although uPAR may play only a minor role in the growth and metastasis of lymphoma, β1 integrin may be important in predicting prognosis and metastasis in HL.

    Keywords: Hodgkin’s lymphoma, metastasis, soluble urokinase plasminogen activator receptor, urokinase plasminogen activator receptor, β1 integrin}
  • S Pourrezaei, A Jafarpour, Sh Aghamiri, Hamid Reza Molai, Ali Mohammad Arabzadeh, T Shahani
     
    Background and Aims
    EBV infection usually occurs in humans and is very common. Sero-epidemiological surveys show that over 95% of adults worldwide are faced with EBV virus. The Epstein-Barr virus causes infectious mononucleosis and its association with a number of human cancers, including Hodgkin's lymphoma, non-Hodgkin lymphoma (especially lymphoma BL), nasopharyngeal carcinoma, gastric carcinoma and breast cancer has been established.
    Materials and Methods
    This study was conducted cross-sectional. This study was designed to determine the presence of the Epstein-Barr virus genome in tissue samples of patients with Hodgkin lymphoma and non-Hodgkins. In this study, 40 samples of patients with non-Hodgkin's lymphoma and Hodgkin's disease, while had been kept in archives of the Shahid Bahonar Hospital, Afzalipour Hospital and Payambar-e-Azam Hospital of Kerman were examined by real-time PCR technique. The data collected by SPSS software and chi-square test were analyzed.
    Results
    The prevalence of EBV in patients in this study was 5/27% of the 40 sample, of which 20 cases were of Hodgkin lymphoma and 20 cases were of non-Hodgkin lymphoma. No significant correlation was found between the prevalence of EBV in Hodgkin and non-Hodgkin lymphoma. There was also no correlation between men and women of different ages for the presence of EBV DNA in patients samples (P>0.05).
    Conclusions
    EBV DNA associated with the tumor could be detected by molecular methods which are useful for the diagnosis of EBV-associated diseases, also biological factors such as age, sex, health status, social and economic factors in the pathogenesis of EBV and its relationship to lymphoma was not observed.
    Keywords: Hodgkin's lymphoma, Non-Hodgkin`s lymphoma, Epstein-Barr Virus, Real -Time-PCR}
  • Valiollah Mehrzad, Farzaneh Ashrafi, AliReza Farrashi, Reyhaneh Pourmarjani, Mehdi Dehghani, Armindokht Shahsanaei
    Background

    Refractory or relapsed Hodgkin’s disease (HD) occurs in 10‑50% of patients. The treatment of choice for these patients is high‑dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT). Response to salvage chemotherapy (SCT) partial remission (PR) is necessary before HDCT with ASCT. However, its applicability is restricted mostly to patients responding to salvage chemotherapy. Optimal salvage regimen for these patients is unclear. In this study, our aim was to compare the efficacy profiles of ifosfamide, carboplatin, and etoposide (ICE) and etoposide‑ steroid‑cytarabine‑cisplatin (ESHAP) (cytosine arabinoside, cisplatin, and dexamethasone) regimens in the salvage treatment of relapsed or refractory HD.

    Materials and Methods

    In this retrospective analysis, 114 patients with primary refractory or relapsed HD who received ICE or ESHAP salvage regimen were included.

    Results

    Of 114 patients, 47 (41.2%) were females and the median age was 31.5 years. Response could be evaluated in 114 patients. Of 114 patients, 38 (33%) achieved complete remission (CR) and 21 (18.4%) achieved PR, leading to an overall response rate (ORR: CR + PR) of 51.4%. In the evaluable ICE group (n = 41), rates of CR, PR, and ORR were 21.9%, 17.1%, and 39% and in the ESHAP group (n = 73), rates of CR, PR, and ORR were 39.7%, 19.2%, and 58.9% (for ORR, P = 0.04), respectively.

    Conclusion

    In patients with relapsed or refractory HD, treatment with ESHAP seems to have higher rates of response than ICE regimen does.

    Keywords: Carboplatin, etoposide, etoposide‑steroid‑cytarabine‑cisplatin, Hodgkin’s lymphoma, ifosfamide, refractory, relapse}
  • Amir Sobhani Eraghi, Roozbeh Taghavi*, Ali Radmehr
    Introduction
    Primary non-Hodgkin’s lymphoma of the bone (PLB) represents about 3% - 5% of all extranodal non-Hodgkin’s lymphoma (NHL) cases and 7% of primary bone tumors. It may occur at any age. The peak incidence for PLB is in the fifth and sixth decades of life, and it has a slight male predominance. The most commonly affected sites are the long bones. A palpable mass due to soft tissue extension of the bony disease is seen in almost half of all cases.
    Case Presentation
    We report the case of an NHL (diffuse large B-cell lymphoma) in the talus bone of a 17-year-old boy who was referred to our center in 2011 - 2012, which had an odd presentation. The patient’s first diagnosis was a simple ankle sprain, and he underwent conservative treatment. Given the patient’s deteriorating symptoms, further paraclinical evaluations were conducted, and fracture of the talus was diagnosed, which was thought to be a cause of further osteonecrosis. Finally, because of lack of pain relief and due to MRI images, the suspicion of malignancy was raised. Open biopsy of the talus showed NHL (diffuse large B-cell lymphoma).
    Conclusions
    The present case is interesting because it expresses how such lesions can be met with diagnostic confusion.
    Keywords: Primary Non, Hodgkin's Lymphoma, Talus, Combined Therapy, Osteonecrosis}
  • Geetha Narayanan *, T. Manohar Anoop, Lakshmi Haridas, Lali V. Soman
    Survival of patients with multiple myeloma has improved substantially because of availability of new therapies including autotransplants, immunomodulating drugs and proteasome-inhibitors. Second primary cancers have emerged as an important determinant of morbidity and mortality among cancer survivors. Even though there is an increased risk of new cancers of the lymphoreticular and haematopoetic system, it is very rare for Hodgkin’s lymphoma to occur as a second malignancy following autologous peripheral blood stem cell transplantation (APBSCT) for myeloma. We report a case of a female with plasma cell leukemia treated with autologous peripheral blood stem cell transplantation and lenalidamide maintenance. She developed cervical lymphadenopathy 4.5 years after the APBSCT, biopsy confirmed the diagnosis of classical Hodgkin’s lymphoma, nodular sclerosis type. Since she developed allergic reaction to ABVD, she was given 6 cycles of COPP chemotherapy and is in complete remission now.
    Keywords: Hodgkin's lymphoma, Plasma cell leukemia, Second malignancy, Stem cell transplantation}
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال